Genomic structure and embryonic expression of the rat type 1 vasoactive intestinal polypeptide receptor gene

Regulatory Peptides

Volumn 71, Issue 3, 1997, Pages 153-161

  Pei, Lin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Development; Embryology; Genomic structure; Histochemistry; Vasoactive intestinal protein type I receptor (VIP I)

Indexed keywords

MESSENGER RNA; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ARTICLE; DNA SEQUENCE; EMBRYO; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENE STRUCTURE; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA ANALYSIS; TISSUE DISTRIBUTION;

ANIMALS; EMBRYO; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IN SITU HYBRIDIZATION; RATS; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 0030847522     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(97)01012-4     Document Type: Article

References (32)

1. Waschek J.A. Vasoactive intestinal peptide: An important trophic factor and development regulator? Dev. Neurosci. 17:1995;1-7.
2. Pincus D.W., DiCicco-Bloom E.M., Black I.B. Vasoactive intestinal peptide regulation of neuroblast mitosis, differentiation and survival: role of cAMP. Brain Res. 514:1990;355-357.
3. Pincus D.W., DiCicco-Bloom E.M., Black I.B. Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts. Nature. 343:1990;564-567.
4. Brenneman D.E., Nicol T., Warren D., Bowers L.M. Vasoactive intestinal peptide: a neurotrophic releasing agent and an astroglial mitogen. J. Neurosci. Res. 25:1990;386-394.
5. Haegerstrand A., Jonzon B., Dalsgaard C.J., Nilsson J. Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes. Proc. Natl. Acad. Sci. U.S.A. 86:1989;5993-5996.
6. Takahashi K., Nakanishi S., Imamura S. Direct effects of cutaneous neuropeptides on adenylyl cyclase activity and proliferation in a keratinocyte cell line: stimulation of cyclic AMP formation by CGRP and VIP/PHM, and inhibition by NPY through G protein-coupled receptors. J. Invest. Dermatol. 101:1993;646-651.
7. 2+ and protein kinase C. Exp. Cell Res. 176:1988;155-161.
8. Moody T.W., Zia F., Goldstein A.L., Naylor P.H., Sarin E., Brenneman D.E.et al. VIP analogue inhibits small cell lung cancer growth. Biomed. Res. 13 S2:1992;131-136.
9. Maruno K., Said S.I. Vasoactive intestinal peptide inhibits the proliferation of human small cell lung carcinoma. Biomed. Res. 13 S2:1992;373-376.
10. Maruno K., Said S.I. Small-cell lung carcinoma: inhibition of proliferation by vasoactive intestinal peptide and helodermin and enhancement of inhibition by anti-bombesin antibody. Life Sci. 52:1993;267-271.
11. Gamet L., Murat J.C., Remaury A., Remesy C., Valet P., Paris H.et al. Vasoactive intestinal peptide and forskolin regulate proliferation of the HT29 human colon adenocarcinoma cell line. J. Cell. Physiol. 150:1992;501-509.
12. Kim S.W., Beauchamp R.D., Townsend C.M. Jr., Thompson J.C. Vasoactive intestinal polypeptide inhibits c-myc expression and growth of human gastric carcinoma cells. Surgery. 110:1991;270-276.
13. Agoston D.V., Eiden L.E., Brenneman D.E., Gozes I. Spontaneous electric activity regulates vasoactive intestinal peptide expression in dissociated spinal cord cell cultures. Mol. Brain Res. 10:1991;235-240.
14. Olah Z., Komoly S., Warren D., Brenneman D.E., Agoston D.V. Protein kinase C-related signal transduction pathway is triggered by subnanomolar concentration of VIP in astrocytes. Soc. Neurosci. Abstr. 17:1991;603.
15. Russell J.T., Fatatis A., Nelson P.G., Brenneman D.V. Vasoactive intestinal polypeptide (VIP) causes intracellular calcium oscillations in astrocytes. Soc. Neurosci. Abstr. 16:1990;994.
16. Tatsuno I., Yada T., Vigh S., Hidaka H., Arimura A. Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide increase cytosolic free calcium concentration in cultured rat hippocampal neurons. Endocrinology. 131:1992;73-81.
17. Gressens P., Hill J.M., Gozes I., Fridkin M., Brenneman D.E. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature. 362:1993;155-158.
18. Hill J.M., Agoston D.V., Gressens P., McCune S.K. Distribution of VIP mRNA and two distinct VIP binding sites in the developing rat brain: relation to ontogenic event. J. Comp. Neurol. 342:1994;186-205.
19. Ishihara T., Shigemoto R., Mori K., Takahashi K., Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron. 8:1992;811-819.
20. Sreedharan S.P., Patel D.R., Huang J.-X., Goetzl E.J. Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor. Biochem. Biophys. Res. Commun. 193:1993;546-553.
21. Couvineau A., Rouyer-Fessard C., Darmoul D., Maoret J.-J., Carrero I., Ogier-Denis E., Laburthe M. Human VIP receptor: cloning and functional expression of two cDNA encoding proteins with different N-terminal domains. Biochem. Biophys. Res. Commun. 200:1994;769-776.
22. Lutz E.M., Sheward W.J., West K.M., Morrow J.A., Fink G., Harmar A.J. The VIP2 receptor: Molecular characterization of cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett. 334:1993;3-8.
23. Harmar T., Lutz E. Multiple receptors for PACAP and VIP. Trends Pharmacol. Sci. 15:1994;97-99.
24. Usdin T.B., Bonner T.I., Mezey E. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distribution. Endocrinology. 135:1994;2662-2680.
25. Pei L., Melmed S. Characterization of the VIP receptor gene 5′ region. Biochem. J. 308:1995;719-723.
26. Pei L. Identification of a negative glucocorticoid response element in the rat type 1 VIP receptor gene. J. Biol. Chem. 271:1996;20879-20884.
27. Sreedharan S.P., Huang J.-X., Cheung M.-C., Goetzl E.J. Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. Proc. Natl. Acad. Sci. U.S.A. 92:1995;2939-2943.
28. Waschek J.A., Ellison J., Bravo D.T., Handley V. Embryonic expression of vasoactive intestinal peptide (VIP) and VIP receptor genes. J. Neurochem. 66:1996;1762-1765.
29. Said S.I. Vasoactive intestinal polypeptide: Biological role in health and disease. Trends Endocrinol. Metab. 2:1991;107-112.
30. Ichikawa S., Sreedharan S.P., Owen R.L., Goetzl E.J. Immunochemical localization of type I VIP receptor and NK-1-type substance P receptor in rat lung. Am. J. Physiol. 268:1995;L584-L588.
31. Sakakibara H., Shima K., Said S.I. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages. Am. J. Physiol. 267:1994;L256-L262.
32. Kiyama H. Recent progress in the use of the techniques in molecular histochemistry. Jpn. J. Thorac. Dis. 31 Suppl. 1993;100-107.